IYH:NYE-iShares U.S. Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 57.82

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.40M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-03 )

ETFs Containing IYH

RXD ProShares UltraShort Heal.. 10.32 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 10.32 % 0.95 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.77% 62% D 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.77% 62% D 54% F
Trailing 12 Months  
Capital Gain -2.43% 38% F 36% F
Dividend Return 0.94% 81% B- 19% F
Total Return -1.48% 43% F 31% F
Trailing 5 Years  
Capital Gain 38.53% 86% B+ 51% F
Dividend Return 7.28% 74% C 15% F
Total Return 45.82% 86% B+ 43% F
Average Annual (5 Year Horizon)  
Capital Gain 4.39% 76% C+ 53% F
Dividend Return 5.38% 76% C+ 48% F
Total Return 1.00% 79% B- 24% F
Risk Return Profile  
Volatility (Standard Deviation) 17.52% 48% F 57% F
Risk Adjusted Return 30.72% 71% C- 48% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.